Fiche publication
Date publication
juillet 2019
Journal
Cancer
Auteurs
Lien Pubmed
Résumé
The continuation of preventive drugs among older patients with advanced cancer has come under scrutiny because these drugs are unlikely to achieve their clinical benefit during the patients' remaining lifespan.
Mots clés
deprescribing, drug prescribing, end of life, palliative care
Référence
Cancer. 2019 07 1;125(13):2309-2317
